DrugPatentWatch Database Preview

DOPAMINE HYDROCHLORIDE Drug Patent Profile

Email this page to a colleague

« Back to Dashboard

When do Dopamine Hydrochloride patents expire, and when can generic versions of Dopamine Hydrochloride launch?

Dopamine Hydrochloride is a drug marketed by Abbott, Abraxis Pharm, Am Regent, Baxter Hlthcare, Hikma Intl Pharms, Hospira, Igi Labs Inc, Intl Medication, Lyphomed, Smith And Nephew, Teligent, Teva Parenteral, Warner Chilcott, and B Braun. and is included in thirty-six NDAs.

The generic ingredient in DOPAMINE HYDROCHLORIDE is dopamine hydrochloride. There are nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the dopamine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Dopamine Hydrochloride

A generic version of DOPAMINE HYDROCHLORIDE was approved as dopamine hydrochloride by HOSPIRA on February 4^th, 1982.

Summary for DOPAMINE HYDROCHLORIDE

US Patents:	0
Applicants:	14
NDAs:	36
Finished Product Suppliers / Packagers:	6
Raw Ingredient (Bulk) Api Vendors:	139
Clinical Trials:	927
Patent Applications:	1,144
Formulation / Manufacturing:	see details
What excipients (inactive ingredients) are in DOPAMINE HYDROCHLORIDE?	DOPAMINE HYDROCHLORIDE excipients list
DailyMed Link:	DOPAMINE HYDROCHLORIDE at DailyMed

Recent Clinical Trials for DOPAMINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Stephen G. Kaler, MD	Phase 1/Phase 2
Central South University	N/A
Cairo University	Phase 4

See all DOPAMINE HYDROCHLORIDE clinical trials

Pharmacology for DOPAMINE HYDROCHLORIDE

Drug Class

Catecholamine

Medical Subject Heading (MeSH) Categories for DOPAMINE HYDROCHLORIDE

Cardiotonic Agents

Dopamine Agents

Sympathomimetics

Anatomical Therapeutic Chemical (ATC) Classes for DOPAMINE HYDROCHLORIDE

C01CA	Adrenergic and dopaminergic agents
C01C	CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
C01	CARDIAC THERAPY
C	Cardiovascular system

US Patents and Regulatory Information for DOPAMINE HYDROCHLORIDE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
B Braun	DOPAMINE HYDROCHLORIDE AND DEXTROSE 5% IN PLASTIC CONTAINER	dopamine hydrochloride	INJECTABLE;INJECTION	019099-003	Oct 15, 1986	AP	RX	Yes	Yes
Teligent	DOPAMINE HYDROCHLORIDE	dopamine hydrochloride	INJECTABLE;INJECTION	018656-001	Jun 28, 1983		DISCN	No	No
Hospira	DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	dopamine hydrochloride	INJECTABLE;INJECTION	018826-003	Sep 30, 1983	AP	RX	Yes	Yes
Baxter Hlthcare	DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	dopamine hydrochloride	INJECTABLE;INJECTION	019615-003	Mar 27, 1987	AP	RX	Yes	Yes
Lyphomed	DOPAMINE HYDROCHLORIDE	dopamine hydrochloride	INJECTABLE;INJECTION	018549-001	Mar 11, 1983		DISCN	No	No
Teva Parenteral	DOPAMINE HYDROCHLORIDE	dopamine hydrochloride	INJECTABLE;INJECTION	072999-001	Oct 23, 1991		DISCN	No	No
Smith And Nephew	DOPAMINE HYDROCHLORIDE	dopamine hydrochloride	INJECTABLE;INJECTION	070011-001	Aug 29, 1985		DISCN	No	No